Expression and clinical significance of Trop-2 in human pancreatic cancer

National Medical Journal of China

Volumn 91, Issue 2, 2011, Pages 103-106

  Qiu, Jin Rong ^a   Tang, Qi ^c   Lin, Hong ^c   Wang, Zhong Can ^b   Li, Yu Hua ^c   Zhu, Jin ^b  

^a NANJING MEDICAL UNIVERSITY   (China)

^b Huadong Medical Institute of Biotechniques   (China)

^c NONE

Author keywords

Gene expression; Pancreatic neoplasms; Trop 2

Indexed keywords

PROTEIN; PROTEIN TROP 2; UNCLASSIFIED DRUG; CELL ADHESION MOLECULE; MESSENGER RNA; TACSTD2 PROTEIN, HUMAN; TUMOR ANTIGEN;

ARTICLE; CLINICAL FEATURE; DISEASE COURSE; HUMAN; IMMUNOFLUORESCENCE TEST; IMMUNOHISTOCHEMISTRY; PANCREAS CANCER; PROTEIN EXPRESSION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; TISSUE MICROARRAY; ADULT; AGED; FEMALE; GENETICS; MALE; METABOLISM; MIDDLE AGED; PANCREAS TUMOR; PATHOLOGY;

ADULT; AGED; AGED, 80 AND OVER; ANTIGENS, NEOPLASM; CELL ADHESION MOLECULES; FEMALE; HUMANS; MALE; MIDDLE AGED; PANCREATIC NEOPLASMS; RNA, MESSENGER;

EID: 84869219726     PISSN: 03762491     EISSN: None     Source Type: Journal    
DOI: 10.3760/cma.j.issn.0376-2491.2011.02.009     Document Type: Article

References (14)

1. Fong D, Moser P, Krammel C, et al. High expression of TROP2 correlates with poor prognosis in pancreatic cancer. Br J Cancer, 2008, 99: 1290-1295.
2. 2007, 27: 1908-1910.
3. Fong D, Spizzo G, Gostner JM, et al. TROP2: a novel prognostic marker in squamous cell carcinoma of the oral cavity. Mod Pathol, 2008, 21: 186-191.
4. Bignotti E, Todeschini P, Calza S, et al. Trop-2 overexpression as an independent marker for poor overall survival in ovarian carcinoma patients. Eur J Cancer, 2010, 46: 944-953.
5. Mühlmann G, Spizzo G, Gostner J, et al. TROP2 expression as prognostic marker for gastric carcinoma. J Clin Pathol, 2009, 62: 152-158.
6. Fang YJ, Lu ZH, Wang GQ, et al. Elevated expressions of MMP7, TROP2, and survivin are associated with survival, disease recurrence, and liver metastasis of colon cancer. Int J Colorectal Dis, 2009, 24: 875-884.
7. Hamilton SR, Aaltonen LA. Pathology and Genetics. Tumours of the Digestive System. World Health Organization Classification of Tumours. Lyon: IARC Press, 2000: 157-172.
8. Tang Q, Liu YF, Zhu XJ, et al. Expression and prognostic significance of the alpha B-crystallin gene in human hepatocellular carcinoma. Hum Pathol, 2009, 40: 300-305.
9. Lipinski M, Parks DR, Rouse RV, et al. Human trophoblast cell-surface antigens defined by monoclonal antibodies. Proc Natl Acad Sci USA, 1981, 78: 5147-5150.
10. Alberti S, Miotti S, Stella M, et al. Biochemical characterization of Trop-2, a cell surface molecule expressed by human carcinomas: formal proof that the monoclonal antibodies T16 and MOv-16 recognize Trop-2. Hybridoma, 1992, 11: 539-545.
11. Fornaro M, Dell'Arciprete R, Stella M, et al. Cloning of the gene encoding Trop-2, a cell-surface glycoprotein expressed by human carcinomas. Int J Cancer, 1995, 62: 610-618.
12. Schön MP, Orfanos CE. Transformation of human keratinocytes is characterized by quantitative and qualitative alterations of the T-16 antigen (Trop-2, MOv-16). Int J Cancer, 1995, 60: 88-92.
13. 2006, 26: 734-736.
14. Deckert PM. Current constructs and targets in clinical development for antibody-based cancer therapy. Curr Drug Targets, 2009, 10: 158-175.